Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Issue Highlights-May 2018 (94B3).

Wallace PK.

Cytometry B Clin Cytom. 2018 May;94(3):387-391. doi: 10.1002/cyto.b.21640. No abstract available.

PMID:
29734502
2.

Welcome to Prague CYTO 2018.

Cossarizza A, Wallace PK.

Cytometry A. 2018 Mar;93(3):267-268. doi: 10.1002/cyto.a.23350. No abstract available.

PMID:
29579366
3.

Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors.

Liu C, Yu T, Xing Z, Jiang X, Li Y, Pao A, Mu J, Wallace PK, Stoica G, Bakin AV, Yu YE.

Oncotarget. 2017 Dec 19;9(4):4773-4786. doi: 10.18632/oncotarget.23463. eCollection 2018 Jan 12.

4.

BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia.

Amro Elshoury, Wallace PK, Borowitz MJ, Kader A, Choi C, Ho C, Balderman S, Ross M, Hahn T, O'Neill V, McCarthy PL, Chen GL.

Bone Marrow Transplant. 2018 May;53(5):651-653. doi: 10.1038/s41409-017-0036-x. Epub 2018 Jan 17. No abstract available.

PMID:
29343836
5.

Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses.

Shenoy GN, Loyall J, Maguire O, Iyer V, Kelleher RJ Jr, Minderman H, Wallace PK, Odunsi K, Balu-Iyer SV, Bankert RB.

Cancer Immunol Res. 2018 Feb;6(2):236-247. doi: 10.1158/2326-6066.CIR-17-0113. Epub 2018 Jan 4.

6.

Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT.

Ho CM, McCarthy PL, Wallace PK, Zhang Y, Fora A, Mellors P, Tario JD, McCarthy BLS, Chen GL, Holstein SA, Balderman SR, Cao X, Paiva B, Hahn T.

Blood Adv. 2017 Jun 20;1(15):1056-1066. doi: 10.1182/bloodadvances.2017005447. eCollection 2017 Jun 27.

7.

CYTO Asia 2017 meeting highlights.

Hutchinson PE, Wallace PK, Nguyen V.

Cytometry A. 2017 Dec;91(12):1143-1146. doi: 10.1002/cyto.a.23297. No abstract available.

PMID:
29265734
8.

ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 4 - assay validation and quality assurance.

Oldaker T, Whitby L, Saber M, Holden J, Wallace PK, Litwin V.

Cytometry B Clin Cytom. 2018 Jan;94(1):67-81. doi: 10.1002/cyto.b.21615.

PMID:
29251828
9.

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.

Holstein SA, Avet-Loiseau H, Hahn T, Ho CM, Lohr JG, Munshi NC, Paiva B, Pasquini MC, Tario JD Jr, Usmani SZ, Wallace PK, Weisel K, McCarthy PL.

Biol Blood Marrow Transplant. 2018 Apr;24(4):641-648. doi: 10.1016/j.bbmt.2017.12.774. Epub 2017 Dec 11. Review.

PMID:
29242112
10.

ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 - reagent selection and assay optimization for high-sensitivity testing.

Sutherland DR, Illingworth A, Marinov I, Ortiz F, Andreasen J, Payne D, Wallace PK, Keeney M.

Cytometry B Clin Cytom. 2018 Jan;94(1):23-48. doi: 10.1002/cyto.b.21610.

PMID:
29236353
11.

Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.

Soh KT, Tario JD Jr, Wallace PK.

Clin Lab Med. 2017 Dec;37(4):821-853. doi: 10.1016/j.cll.2017.08.001. Review.

12.

Monitoring Cell Proliferation by Dye Dilution: Considerations for Probe Selection.

Tario JD Jr, Conway AN, Muirhead KA, Wallace PK.

Methods Mol Biol. 2018;1678:249-299. doi: 10.1007/978-1-4939-7346-0_12.

13.

RNA Flow Cytometry Using the Branched DNA Technique.

Soh KT, Wallace PK.

Methods Mol Biol. 2018;1678:49-77. doi: 10.1007/978-1-4939-7346-0_4.

14.

Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Venuto CS, Markatou M, Woolwine-Cunningham Y, Furlage R, Ocque AJ, DiFrancesco R, Dumas EO, Wallace PK, Morse GD, Talal AH.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02283-16. doi: 10.1128/AAC.02283-16. Print 2017 May.

15.

Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML.

Vachhani P, Mendler JH, Evans A, Deeb G, Starostik P, Wallace PK, Wang ES.

Case Rep Hematol. 2016;2016:1259759. doi: 10.1155/2016/1259759. Epub 2016 Dec 29.

16.

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph JM, Mayor P, Abrams SI, Segal BH, Wallace PK, Soh KT, Zsiros E, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bjorge L, Bruegl A, Campbell IG, Campbell SP, Chenevix-Trench G, Cramer DW, Dansonka-Mieszkowska A, Dao F, Diergaarde B, Doerk T, Doherty JA, du Bois A, Eccles D, Engelholm SA, Fasching PA, Gayther SA, Gentry-Maharaj A, Glasspool RM, Goodman MT, Gronwald J, Harter P, Hein A, Heitz F, Hillemmanns P, Høgdall C, Høgdall EV, Huzarski T, Jensen A, Johnatty SE, Jung A, Karlan BY, Klapdor R, Kluz T, Konopka B, Kjær SK, Kupryjanczyk J, Lambrechts D, Lester J, Lubiński J, Levine DA, Lundvall L, McGuire V, McNeish IA, Menon U, Modugno F, Ness RB, Orsulic S, Paul J, Pearce CL, Pejovic T, Pharoah P, Ramus SJ, Rothstein J, Rossing MA, Rübner M, Schildkraut JM, Schmalfeldt B, Schwaab I, Siddiqui N, Sieh W, Sobiczewski P, Song H, Terry KL, Van Nieuwenhuysen E, Vanderstichele A, Vergote I, Walsh CS, Webb PM, Wentzensen N, Whittemore AS, Wu AH, Ziogas A, Odunsi K, Chang-Claude J, Goode EL, Moysich KB; Australian Ovarian Cancer Study.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):420-424. doi: 10.1158/1055-9965.EPI-16-0631. Epub 2016 Sep 27.

17.

Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1.

Thomas LJ, Vitale L, O'Neill T, Dolnick RY, Wallace PK, Minderman H, Gergel LE, Forsberg EM, Boyer JM, Storey JR, Pilsmaker CD, Hammond RA, Widger J, Sundarapandiyan K, Crocker A, Marsh HC Jr, Keler T.

Mol Cancer Ther. 2016 Dec;15(12):2946-2954. Epub 2016 Sep 26.

18.

Total cellular protein presence of the transcription factor IRF8 does not necessarily correlate with its nuclear presence.

Minderman H, Maguire O, O'Loughlin KL, Muhitch J, Wallace PK, Abrams SI.

Methods. 2017 Jan 1;112:84-90. doi: 10.1016/j.ymeth.2016.08.011. Epub 2016 Aug 28.

19.

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.

Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, Kelemen LE, Goodman MT, Bandera EV, Terry KL, Schoof N, Eng KH, Clay A, Singh PK, Joseph JM, Aben KK, Anton-Culver H, Antonenkova N, Baker H, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Despierre E, Dicks E, Doherty JA, du Bois A, Dürst M, Easton D, Eccles D, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Gronwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hogdall C, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kelley JL, Kiemeney LA, Klapdor R, Kolomeyevskaya N, Krakstad C, Kjaer SK, Kruszka B, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Liu S, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Moes-Sosnowska J, Narod SA, Nedergaard L, Nevanlinna H, Nickels S, Olson SH, Orlow I, Weber RP, Paul J, Pejovic T, Pelttari LM, Perkins B, Permuth-Wey J, Pike MC, Plisiecka-Halasa J, Poole EM, Risch HA, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schmitt K, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Tangen IL, Teo SH, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, Tyrer J, van Altena AM, Vergote I, Vierkant RA, Walsh C, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Gayther SA, Ramus SJ, Sellers TA, Schildkraut JM, Phelan CM, Berchuck A, Chenevix-Trench G, Cunningham JM, Pharoah PP, Ness RB, Odunsi K, Goode EL, Moysich KB.

Oncotarget. 2016 Oct 25;7(43):69097-69110. doi: 10.18632/oncotarget.10215.

20.

Fluorescent In Situ Hybridization in Suspension by Imaging Flow Cytometry.

Maguire O, Wallace PK, Minderman H.

Methods Mol Biol. 2016;1389:111-26. doi: 10.1007/978-1-4939-3302-0_7.

21.

Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data.

Rajwa B, Wallace PK, Griffiths EA, Dundar M.

IEEE Trans Biomed Eng. 2017 May;64(5):1089-1098. doi: 10.1109/TBME.2016.2590950. Epub 2016 Jul 13.

22.

Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.

Maguire O, Chen GL, Hahn TE, Brix L, McCarthy PL, Wallace PK, Minderman H.

Methods. 2017 Jan 1;112:75-83. doi: 10.1016/j.ymeth.2016.06.014. Epub 2016 Jun 17.

23.

Proliferation by many other names: Monitoring cell cycle progression and cell division by flow cytometry.

Price KM, Muirhead KA, Wallace PK.

Cytometry A. 2016 Mar;89(3):233-5. doi: 10.1002/cyto.a.22815. Epub 2016 Feb 3. No abstract available.

24.

Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins.

Soh KT, Tario JD Jr, Colligan S, Maguire O, Pan D, Minderman H, Wallace PK.

Curr Protoc Cytom. 2016 Jan 6;75:7.45.1-7.45.33. doi: 10.1002/0471142956.cy0745s75.

25.

Simultaneous measurement of human hematopoietic stem and progenitor cells in blood using multicolor flow cytometry.

Cimato TR, Furlage RL, Conway A, Wallace PK.

Cytometry B Clin Cytom. 2016 Sep;90(5):415-23. doi: 10.1002/cyto.b.21354. Epub 2016 Feb 17.

26.

Effects of omalizumab on T lymphocyte function in inner-city children with asthma.

Gruchalla RS, Sampson HA, Liu AH, Shreffler W, Wallace PK, Togias A, David G, Calatroni A, LeBeau P; Inner-city Asthma Consortium.

Pediatr Allergy Immunol. 2016 May;27(3):328-31. doi: 10.1111/pai.12508. Epub 2016 Feb 18. No abstract available.

27.

Issue highlights--November 2015 (88:B6).

Wallace PK.

Cytometry B Clin Cytom. 2015 Nov-Dec;88(6):355-7. doi: 10.1002/cyto.b.21324. No abstract available.

28.

Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myeloma.

Oldaker TA, Wallace PK, Barnett D.

Cytometry B Clin Cytom. 2016 Jan;90(1):40-6. doi: 10.1002/cyto.b.21276. Epub 2015 Sep 4.

29.

Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.

Kelleher RJ Jr, Balu-Iyer S, Loyall J, Sacca AJ, Shenoy GN, Peng P, Iyer V, Fathallah AM, Berenson CS, Wallace PK, Tario J, Odunsi K, Bankert RB.

Cancer Immunol Res. 2015 Nov;3(11):1269-78. doi: 10.1158/2326-6066.CIR-15-0086. Epub 2015 Jun 25.

30.

Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.

Paulus A, Chitta KS, Wallace PK, Advani PP, Akhtar S, Kuranz-Blake M, Ailawadhi S, Chanan-Khan AA.

PLoS One. 2015 Apr 8;10(4):e0122338. doi: 10.1371/journal.pone.0122338. eCollection 2015.

31.

Human B-cell and progenitor stages as determined by probability state modeling of multidimensional cytometry data.

Bagwell CB, Hill BL, Wood BL, Wallace PK, Alrazzak M, Kelliher AS, Preffer FI.

Cytometry B Clin Cytom. 2015 Jul-Aug;88(4):214-26. doi: 10.1002/cyto.b.21243. Epub 2015 May 23.

32.

Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples.

Tario JD Jr, Chen GL, Hahn TE, Pan D, Furlage RL, Zhang Y, Brix L, Halgreen C, Jacobsen K, McCarthy PL, Wallace PK.

Cytometry B Clin Cytom. 2015 Jan;88(1):6-20. doi: 10.1002/cyto.b.21196. Epub 2014 Oct 23.

33.

Flow cytometry and solid organ transplantation: a perfect match.

Maguire O, Tario JD Jr, Shanahan TC, Wallace PK, Minderman H.

Immunol Invest. 2014;43(8):756-74. doi: 10.3109/08820139.2014.910022. Review.

34.

Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34(+) cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers.

Preti RA, Chan WS, Kurtzberg J, Dornsife RE, Wallace PK, Furlage R, Lin A, Omana-Zapata I, Bonig H, Tonn T.

Cytotherapy. 2014 Nov;16(11):1558-1574. doi: 10.1016/j.jcyt.2014.03.006. Epub 2014 Jun 11.

35.

Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.

Berenson CS, Kruzel RL, Eberhardt E, Dolnick R, Minderman H, Wallace PK, Sethi S.

Thorax. 2014 Sep;69(9):811-8. doi: 10.1136/thoraxjnl-2013-203669. Epub 2014 Mar 31.

PMID:
24686454
36.

Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism.

McCance-Katz EF, Gruber VA, Beatty G, Lum P, Ma Q, DiFrancesco R, Hochreiter J, Wallace PK, Faiman MD, Morse GD.

Am J Addict. 2014 Mar-Apr;23(2):137-44. doi: 10.1111/j.1521-0391.2013.12081.x. Epub 2013 Oct 11.

37.

Hypoxia-inducible C-to-U coding RNA editing downregulates SDHB in monocytes.

Baysal BE, De Jong K, Liu B, Wang J, Patnaik SK, Wallace PK, Taggart RT.

PeerJ. 2013 Sep 10;1:e152. doi: 10.7717/peerj.152. eCollection 2013.

38.

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.

Simpson-Abelson MR, Loyall JL, Lehman HK, Barnas JL, Minderman H, O'Loughlin KL, Wallace PK, George TC, Peng P, Kelleher RJ Jr, Odunsi K, Bankert RB.

Cancer Immun. 2013 Jul 15;13:14. Print 2013.

39.

Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.

Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB.

Breast Cancer Res Treat. 2013 Jun;139(2):477-88. doi: 10.1007/s10549-013-2549-3. Epub 2013 Apr 30.

40.

Optimized staining and proliferation modeling methods for cell division monitoring using cell tracking dyes.

Tario JD Jr, Humphrey K, Bantly AD, Muirhead KA, Moore JS, Wallace PK.

J Vis Exp. 2012 Dec 13;(70):e4287. doi: 10.3791/4287.

41.

CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations.

Francis J, Dharmadhikari AV, Sait SN, Deeb G, Wallace PK, Thompson JE, Wang ES, Wetzler M.

Leuk Lymphoma. 2013 Jul;54(7):1517-20. doi: 10.3109/10428194.2012.754096. Epub 2013 Jan 3.

PMID:
23193950
42.

Predictors of immunosuppressive regulatory T lymphocytes in healthy women.

Hampras SS, Nesline M, Wallace PK, Odunsi K, Furlani N, Davis W, Moysich KB.

J Cancer Epidemiol. 2012;2012:191090. doi: 10.1155/2012/191090. Epub 2012 Aug 26.

43.

Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension.

Minderman H, Humphrey K, Arcadi JK, Wierzbicki A, Maguire O, Wang ES, Block AW, Sait SN, George TC, Wallace PK.

Cytometry A. 2012 Sep;81(9):776-84. doi: 10.1002/cyto.a.22101. Epub 2012 Jul 26.

44.

T-cell large granular lymphocytosis associated with malignant thymoma.

Herko A, Pophali P, Wallace PK, Sharma P, Loud P, Khoury T, Battiwalla M.

Leuk Res. 2012 Aug;36(8):e187-9. doi: 10.1016/j.leukres.2012.03.008. Epub 2012 Apr 3. No abstract available.

PMID:
22475364
45.

Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.

Smonskey MT, Block AW, Deeb G, Chanan-Khan AA, Bernstein ZP, Miller KC, Wallace PK, Starostik P.

Am J Clin Pathol. 2012 Apr;137(4):641-6. doi: 10.1309/AJCPP31FSSRQTTAQ.

PMID:
22431542
46.

Case study interpretation--Portland: Case 4. Acute leukemia of ambiguous lineage, unclassifiable.

Merzianu M, Wallace PK.

Cytometry B Clin Cytom. 2012 May;82(3):186-91. doi: 10.1002/cyto.b.21015. Epub 2012 Mar 19. No abstract available.

47.

Longitudinal relationship of early life immunomodulatory T cell phenotype and function to development of allergic sensitization in an urban cohort.

McLoughlin RM, Calatroni A, Visness CM, Wallace PK, Cruikshank WW, Tuzova M, Ly NP, Ruiz-Perez B, Kattan M, Bloomberg GR, Lederman H, Gern JE, Gold DR.

Clin Exp Allergy. 2012 Mar;42(3):392-404. doi: 10.1111/j.1365-2222.2011.03882.x. Epub 2011 Nov 9.

48.

Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time?

Ahluwalia MS, Wallace PK, Peereboom DM.

Cancer. 2012 Apr 1;118(7):1747-53. doi: 10.1002/cncr.26335. Epub 2011 Oct 24. Review.

49.

Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

Chanan-Khan AA, Chitta K, Ersing N, Paulus A, Masood A, Sher T, Swaika A, Wallace PK, Mashtare TL Jr, Wilding G, Lee K, Czuczman MS, Borrello I, Bangia N.

Br J Haematol. 2011 Nov;155(4):457-67. doi: 10.1111/j.1365-2141.2011.08882.x. Epub 2011 Oct 20.

50.

Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.

Wang ES, Zeidan A, Tan W, Wilding GE, Ford LA, Wallace PK, Hahn TE, Battiwalla M, McCarthy PL, Wetzler M.

Leuk Lymphoma. 2012 Oct;53(10):2085-8. doi: 10.3109/10428194.2011.603450. Epub 2011 Sep 6. No abstract available.

PMID:
21740302

Supplemental Content

Loading ...
Support Center